Evaluation of the disease modifying activity of Colchicum luteum Baker in experimental arthritis

被引:40
作者
Nair, Vinod [1 ]
Singh, Surender [1 ]
Gupta, Y. K. [1 ]
机构
[1] All India Inst Med Sci, Dept Pharmacol, New Delhi 110029, India
关键词
Adjuvant arthritis; Anti-inflammatory; Colchicum luteum; Disease modifying; Proinflammatory cytokines; RHEUMATOID-ARTHRITIS; INHIBITION; RATS;
D O I
10.1016/j.jep.2010.09.027
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Colchicum luteum (CL) has been traditionally used in the Unani system of medicine as a chief ingredient of many polyherbal formulations for the treatment of joint pain and rheumatoid arthritis (RA). Aim of the study: To evaluate the antiarthritic activity of CL hydroalcoholic extract (CLHE) in formaldehyde and complete Freund's adjuvant (CFA) induced arthritis. Materials and methods: Arthritis was induced by administration of either formaldehyde (2% v/v) or CFA into the subplantar surface of the hind paw of the animal. Joint swelling was measured on days 8,9 and 10 in formaldehyde induced arthritis and days 3, 7, 14 and 21 in CFA induced arthritis. In order to evaluate the effect of CLHE on disease progression, serum TNF-alpha level and synovial expression of proinflammatory mediators (TNF-R1, IL-6 and IL-1 beta) was determined in CFA induced arthritis. Results: CLHE produced a significant and dose dependent inhibition of joint swelling during the entire duration of the study in both, formaldehyde and CFA induced arthritis. Serum TNF-alpha level was also reduced significantly in a dose dependent manner in all the CLHE treated groups. The expression of proinflammatory mediators (TNF-R1, IL-6 and IL-1 beta) was also found to be less in the CLHE treated group as compared to control. Conclusion: We believe that the antiarthritic activity of CLHE was due to its modulatory effect on the expression of proinflammatory cytokine in the synovium. Our results contribute towards validation of the traditional use of CL in the treatment of RA and other inflammatory joint disorders. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 50 条
  • [21] New disease modifying agents in adult rheumatoid arthritis
    Koh, ET
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2001, 30 (02) : 170 - 173
  • [22] Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies
    Vladimira Boyadzhieva
    Konstantin Tachkov
    Nikolay Stoilov
    Konstantin Mitov
    Rumen Stoilov
    Guenka Petrova
    Rheumatology International, 2022, 42 : 1775 - 1783
  • [23] Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies
    Boyadzhieva, Vladimira
    Tachkov, Konstantin
    Stoilov, Nikolay
    Mitov, Konstantin
    Stoilov, Rumen
    Petrova, Guenka
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (10) : 1775 - 1783
  • [24] Disease-modifying activity of malononitrilamides, derivatives of leflunomide's active metabolite, on models of rheumatoid arthritis
    H. U. Schorlemmer
    R. Kurrle
    R. Schleyerbach
    R. R. Bartlett
    Inflammation Research, 1999, 48 (Suppl 2) : 113 - 114
  • [25] Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation
    Avouac, Jerome
    Molto, Anna
    Allanore, Yannick
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (10) : 973 - 977
  • [26] Evaluation of disease activity markers in relation to dry eye disease in patients with rheumatoid arthritis
    Mohja A. El-Badawy
    Amira R. El-Mahdi
    Samia M. Abd El Rehem
    Weam M. Ebeid
    Rania S. El-Kitkat
    Doaa M. Abdelaziz
    Egyptian Rheumatology and Rehabilitation, 2017, 44 (3) : 111 - 117
  • [27] Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs
    Haruko Ideguchi
    Shigeru Ohno
    Hideaki Hattori
    Akiko Senuma
    Yoshiaki Ishigatsubo
    Arthritis Research & Therapy, 8
  • [28] Evaluation of Scrum Calprotectin Level and Disease Activity in Patients with Rheumatoid Arthritis
    Aghdashi, Mir Amir
    Seyedmardani, Seyedmostafa
    Ghasemi, Sholeh
    Khodamoradi, Zohre
    CURRENT RHEUMATOLOGY REVIEWS, 2019, 15 (04) : 316 - 320
  • [29] Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity
    Michelsen, Brigitte
    Diamantopoulos, Andreas P.
    Hammer, Hilde B.
    Soldal, Dag M.
    Kavanaugh, Arthur
    Haugeberg, Glenn
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (12) : 2108 - 2113
  • [30] Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis
    Nell-Duxneuner, Valerie P.
    Stamm, Tanja A.
    Machold, Klaus P.
    Pflugbeil, Stephan
    Aletaha, Daniel
    Smolen, Josef S.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) : 546 - 549